relapsed vs. refractory data for flt3 inhibitors in aml
Published 4 years ago • 85 plays • Length 5:07Download video MP4
Download video MP3
Similar videos
-
6:38
relapsed/refractory flt3-mutated aml
-
4:13
utilizing flt3 inhibitors in relapsed/refractory aml
-
7:26
targeting flt3 in patients with relapsed/refractory aml
-
1:06
gilteritinib monotherapy shows potential for treatment of relapsed/refractory flt3 aml
-
1:33
what effect does gilteritinib have on flt3 mutated relapsed/refractory aml?
-
2:28
dr. levis on gilteritinib in relapsed/refractory flt3-mutated aml
-
3:27
novel flt3 inhibitors for aml
-
3:00
the devastating effects of relapsed or refractory aml
-
4:47
the use of flt3 inhibitors in aml
-
6:29
admiral: gilteritinib as treatment for patients with relapsed or refractory acute myeloid leukaemia
-
2:26
improving outcomes for flt3-mutated r/r aml
-
7:16
second-generation flt3 inhibitors for aml
-
2:47
advances in the treatment of relapsed/refractory acute myeloid leukemia (aml)
-
5:45
clinical trials in aml: frontline use of flt3 inhibitors
-
3:04
ff-10101-01: a novel flt3 inhibitor for r/r aml
-
5:49
emerging flt3 inhibitors in aml
-
4:05
optimizing use of flt3 inhibitor therapy for aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:37
emerging mutations at relapse in flt3-mutated r/r aml on gilteritinib